5,500 samples measured across thousands of proteins each, released publicly. Parkinson’s is still diagnosed by watching people move — this is an attempt to define it biologically instead.
Photodynamic therapy needs molecules that behave correctly in excited states — which is precisely the calculation classical computers handle worst, and quantum computers should handle best.
A Zika vaccine that generates antibodies could make a later dengue infection worse. So the researchers deliberately engineered the antibody response out and protected with T cells instead.
The market did not applaud. AstraZeneca’s shares fell on the rumour — which tells you what investors think it would be buying.
Running growth genes at extreme rates physically strains the DNA until it breaks. The damage tumours inflict on themselves may be where they are most vulnerable.
Payment on validated hit series, not on approval. The structure says exactly which part of discovery the partners think AI can shorten.
Eleven of twenty Phase 3 starts in 2026 are cancer trials. The dolutegravir patents expire 2028–2030, and that is the deadline the whole plan is set against.
$5.5 billion, 69,000 claims, and no admission. After two failed bankruptcy manoeuvres, the company is settling on ordinary terms.
Antipsychotics treat hallucinations. They do nothing for the cognitive impairment affecting 80% of patients — which is what actually determines whether someone can work or live independently.
Three patients, no control group, and the researchers say so plainly. Two of them stopped getting infections for two years.
Designing a molecule that binds is one problem. Knowing whether a chemist can actually make it is a different one — and generative AI has been bad at it.
Fulcrum’s shareholders keep 5% of the combined company. That number is the whole story of what happens when a lead programme is discontinued over a cancer risk.